In: Biotechnology

Gene Editing with CRISPR Technology: Keeping the Focus on Patients

Ever since a proof-of-concept paper was published in 2012, the gene-editing technique CRISPR-Cas9 has been making waves as a major scientific…

Read More
What Do the Next 7 Years Bring for Medtech?

The past year has seen some shake-up in world news, but it remains to be seen precisely how developments will affect…

Read More
A Bright Future for Pharma and Biotech in 2016

Before 2016 even officially kicked off, the life sciences industry received an early present to the tune of $32 billion. The…

Read More
3-D Printing: Endless Possibilities for the Life Sciences

Although the technology has been around for decades, 3-D printing has in recent years gone mainstream––and all the possibilities it represents…

Read More
Animal Biotechnology Part Two: Advances in the Veterinary Space

As we learned in part one of this series, the field of animal biotechnology consists of two main arms of research….

Read More
Global Science Marketing: Expanding Your Presence Across the Globe

With online communities and communication across labs increasing, science companies find themselves crossing national borders to establish an international presence. There…

Read More
Going to BIO? Top 5 Things to Do While You’re in San Francisco

The BIO International Convention brings together more 15,000 biotechnology and pharma leaders for several days of intensive networking to discover new…

Read More
What You Cared About in 2015

As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts…

Read More
Surviving the J.P. Morgan Healthcare Conference [Plus Insider’s Guide]

Each January, the J.P. Morgan Healthcare Conference – perhaps the life science industry’s largest and most frenzied conference of the year…

Read More
Animal Biotechnology: The Business of Bovine

Pfizer, Johnson & Johnson, GlaxoSmithKline: Human drug developers are household names, but what about animal biotechnology – where does that fit…

Read More